405 related articles for article (PubMed ID: 18292096)
1. Increase in beta-lactam-resistant Proteus mirabilis strains due to CTX-M- and CMY-type as well as new VEB- and inhibitor-resistant TEM-type beta-lactamases.
Aragón LM; Mirelis B; Miró E; Mata C; Gómez L; Rivera A; Coll P; Navarro F
J Antimicrob Chemother; 2008 May; 61(5):1029-32. PubMed ID: 18292096
[TBL] [Abstract][Full Text] [Related]
2. [Characteristic of fluoroquinolone resistant clinical isolates of K. pneumoniae, P. mirabilis and E. coli producing ESBL and AmpC beta-lactamases].
Rzeczkowska M; Piekarska K; Gierczyński R
Med Dosw Mikrobiol; 2012; 64(4):285-95. PubMed ID: 23484420
[TBL] [Abstract][Full Text] [Related]
3. Extended-spectrum {beta}-lactamases and AmpC {beta}-lactamases in ceftiofur-resistant Salmonella enterica isolates from food and livestock obtained in Germany during 2003-07.
Rodríguez I; Barownick W; Helmuth R; Mendoza MC; Rodicio MR; Schroeter A; Guerra B
J Antimicrob Chemother; 2009 Aug; 64(2):301-9. PubMed ID: 19474065
[TBL] [Abstract][Full Text] [Related]
4. Dissemination of Proteus mirabilis isolates harboring CTX-M-14 and CTX-M-3 beta-lactamases at 2 hospitals in Taiwan.
Wu LT; Wu HJ; Chung JG; Chuang YC; Cheng KC; Yu WL
Diagn Microbiol Infect Dis; 2006 Feb; 54(2):89-94. PubMed ID: 16406185
[TBL] [Abstract][Full Text] [Related]
5. First report of the emergence of CTX-M-type extended-spectrum beta-lactamases (ESBLs) as the predominant ESBL isolated in a U.S. health care system.
Lewis JS; Herrera M; Wickes B; Patterson JE; Jorgensen JH
Antimicrob Agents Chemother; 2007 Nov; 51(11):4015-21. PubMed ID: 17724160
[TBL] [Abstract][Full Text] [Related]
6. Occurrence and molecular analysis of extended-spectrum {beta}-lactamase-producing Proteus mirabilis in Hong Kong, 1999-2002.
Ho PL; Ho AY; Chow KH; Wong RC; Duan RS; Ho WL; Mak GC; Tsang KW; Yam WC; Yuen KY
J Antimicrob Chemother; 2005 Jun; 55(6):840-5. PubMed ID: 15857942
[TBL] [Abstract][Full Text] [Related]
7. Dissemination of transferable CTX-M-type extended-spectrum beta-lactamase-producing Escherichia coli in Korea.
Jeong SH; Bae IK; Kwon SB; Lee JH; Song JS; Jung HI; Sung KH; Jang SJ; Lee SH
J Appl Microbiol; 2005; 98(4):921-7. PubMed ID: 15752339
[TBL] [Abstract][Full Text] [Related]
8. Nosocomial outbreak by Proteus mirabilis producing extended-spectrum beta-lactamase VEB-1 in a Korean university hospital.
Kim JY; Park YJ; Kim SI; Kang MW; Lee SO; Lee KY
J Antimicrob Chemother; 2004 Dec; 54(6):1144-7. PubMed ID: 15546971
[TBL] [Abstract][Full Text] [Related]
9. Interspecies spread of CTX-M-32 extended-spectrum beta-lactamase and the role of the insertion sequence IS1 in down-regulating bla CTX-M gene expression.
Fernández A; Gil E; Cartelle M; Pérez A; Beceiro A; Mallo S; Tomás MM; Pérez-Llarena FJ; Villanueva R; Bou G
J Antimicrob Chemother; 2007 May; 59(5):841-7. PubMed ID: 17332005
[TBL] [Abstract][Full Text] [Related]
10. Use of boronic acid disk methods to detect the combined expression of plasmid-mediated AmpC beta-lactamases and extended-spectrum beta-lactamases in clinical isolates of Klebsiella spp., Salmonella spp., and Proteus mirabilis.
Song W; Jeong SH; Kim JS; Kim HS; Shin DH; Roh KH; Lee KM
Diagn Microbiol Infect Dis; 2007 Mar; 57(3):315-8. PubMed ID: 17174510
[TBL] [Abstract][Full Text] [Related]
11. Frequency and diversity of Class A extended-spectrum beta-lactamases in hospitals of the Auvergne, France: a 2 year prospective study.
De Champs C; Chanal C; Sirot D; Baraduc R; Romaszko JP; Bonnet R; Plaidy A; Boyer M; Carroy E; Gbadamassi MC; Laluque S; Oules O; Poupart MC; Villemain M; Sirot J
J Antimicrob Chemother; 2004 Sep; 54(3):634-9. PubMed ID: 15282240
[TBL] [Abstract][Full Text] [Related]
12. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae.
Dallenne C; Da Costa A; Decré D; Favier C; Arlet G
J Antimicrob Chemother; 2010 Mar; 65(3):490-5. PubMed ID: 20071363
[TBL] [Abstract][Full Text] [Related]
13. Molecular diversity of Proteus mirabilis isolates producing extended-spectrum beta-lactamases in a French university hospital.
Biendo M; Thomas D; Laurans G; Hamdad-Daoudi F; Canarelli B; Rousseau F; Castelain S; Eb F
Clin Microbiol Infect; 2005 May; 11(5):395-401. PubMed ID: 15819867
[TBL] [Abstract][Full Text] [Related]
14. The first detection of CTX-M-14 extended-spectrum beta-lactamase among diverse beta-lactamase-producing Proteus mirabilis clinical isolates.
Yong D; Lim YS; Roh KH; Choi YS; Park DY; Yum JH; Kim JM; Lee K; Chong Y
Diagn Microbiol Infect Dis; 2006 Mar; 54(3):237-9. PubMed ID: 16427241
[TBL] [Abstract][Full Text] [Related]
15. Spread of multidrug-resistant Proteus mirabilis isolates producing an AmpC-type beta-lactamase: epidemiology and clinical management.
Luzzaro F; Brigante G; D'Andrea MM; Pini B; Giani T; Mantengoli E; Rossolini GM; Toniolo A
Int J Antimicrob Agents; 2009 Apr; 33(4):328-33. PubMed ID: 19095415
[TBL] [Abstract][Full Text] [Related]
16. High diversity of extended-spectrum beta-lactamases among clinical isolates of Enterobacteriaceae from Portugal.
Machado E; Coque TM; Cantón R; Novais A; Sousa JC; Baquero F; Peixe L;
J Antimicrob Chemother; 2007 Dec; 60(6):1370-4. PubMed ID: 17913717
[TBL] [Abstract][Full Text] [Related]
17. [The incidence of extended spectrum beta-lactamases in Proteus mirabilis strains isolated in 2007-2009].
Kwiecińska-Piróg J; Bogiel T; Gospodarek E
Przegl Epidemiol; 2010; 64(3):395-8. PubMed ID: 20976952
[TBL] [Abstract][Full Text] [Related]
18. [Plasmid-mediated AMPc producing Proteus mirabilis in the Health Care Area of Santiago de Compostela: molecular and epidemiological analysis by rep-PCR and MALDI-TOF].
Treviño M; Navarro D; Barbeito G; Areses P; García-Riestra C; Regueiro BJ
Rev Esp Quimioter; 2012 Jun; 25(2):122-8. PubMed ID: 22707100
[TBL] [Abstract][Full Text] [Related]
19. Detection of plasmid-mediated AmpC in Escherichia coli, Klebsiella pneumoniae and Proteus mirabilis.
Tan TY; Ng SY; Teo L; Koh Y; Teok CH
J Clin Pathol; 2008 May; 61(5):642-4. PubMed ID: 18057079
[TBL] [Abstract][Full Text] [Related]
20. Rapidly spreading CTX-M-type beta-lactamase-producing Proteus mirabilis in Japan.
Kanayama A; Iyoda T; Matsuzaki K; Saika T; Ikeda F; Ishii Y; Yamaguchi K; Kobayashi I
Int J Antimicrob Agents; 2010 Oct; 36(4):340-2. PubMed ID: 20609568
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
